<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01942044</url>
  </required_header>
  <id_info>
    <org_study_id>HOtake1</org_study_id>
    <nct_id>NCT01942044</nct_id>
  </id_info>
  <brief_title>Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)</brief_title>
  <official_title>Impact of Stent Platform on Shear Stress Distribution and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kobe University</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Marquette University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kobe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the differences of wall shear stress distribution
      among different types of drug-eluting stents and its impact on vessel healing evaluated by
      intravascular optical coherence tomography evaluation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Distribution of wall shear stress (WSS) may be different according to stent
      designs. The impact of WSS after stent implantation may impact future vessel healing after
      current generation drug-eluting stents implantation. Although previous studies used IVUS
      (intravascular ultrasound) and angiography to determine WSS from computational fluid dynamics
      (CFD) simulations, new methods using higher resolution OCT (optical coherence tomography) are
      warranted to further evaluate the impact of stent design on WSS with current generation
      drug-eluting stents.

      Methods: For these purpose, we will enroll a total of 30 patients with stable angina who are
      scheduled for percutaneous coronary intervention. Those patients were randomized to
      thin-strut (81μm) 2-link Promus element (PE: n=10), thin-strut (81μm) 3-link Xience Prime
      (XP: n=10), or thick-strut (145μm) 2-link Nobori stents (NO: n=10) and underwent OCT and
      coronary CT angiography (CTA) after stenting. Post stent WSS was calculated using CFD
      simulations based on patient-specific reconstructed 3D arteries created by the fusion of OCT
      and CTA data, normalized using WSS in the proximal unstented region. Also, follow-up
      angiography and OCT are performed for the assessment of vessel healing as well as WSS
      distribution 8months after stent implantation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of uncovered struts</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neointimal thickness</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The percentage of malapposed struts</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of low wall shear stress</measure>
    <time_frame>Baseline</time_frame>
    <description>Baseline area of low wall shear stress will be calculated within 1 month after obtaining post stent OCT and CTA images.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of high oscillatory shear index</measure>
    <time_frame>Baseline</time_frame>
    <description>Baseline area of high oscillatory shear index will be calculated within 1 month after obtaining post stent OCT and CTA images.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of low wall shear stress</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area of high oscillatory shear index</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Promus element</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Promus element is a thin struts, 2-link design, evelolimus-eluting stents.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xience Prime</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Xience Prime is a thin struts, 3-link design, evelolimus-eluting stents.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nobori</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nobori is a thick struts, 2-link design, biolimus-eluting stents.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Promus element, Xience prime, and Nobori</intervention_name>
    <arm_group_label>Promus element</arm_group_label>
    <arm_group_label>Xience Prime</arm_group_label>
    <arm_group_label>Nobori</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Older than 20 years old.

          -  Indication of PCI with Xience prime, Nobori, or Promus element.

          -  Clinical diagnosis of stable angina, unstable angina or silent ischemia with reference
             vessel diameters ranging from 2.5-3.5mm.

          -  Underwent CT angiography before PCI.

          -  To agree to review and record all the clinical course in this research protocol.

        Exclusion Criteria:

          -  Previous history of pancytopenia, liver function, renal dysfunction, hypersensitive
             history of the drug.

          -  Low ejection fraction (LVEF&lt;=30%), an impaired liver function, and renal dysfunction
             (eGFR&lt;=40)

          -  Severe calcification

          -  Stent restenosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hiromasa Otake, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kobe University Graduate School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hiromasa Otake, MD, PhD</last_name>
    <phone>+81.78.382.5846</phone>
    <email>hotake@med.kobe-u.ac.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kobe University Graduate School of Medicine</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <zip>650-0017</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiromasa Otake, MD, PhD</last_name>
      <phone>+81.78.382.5846</phone>
      <email>hotake@med.kobe-u.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Toshiro Shinke, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2013</study_first_submitted>
  <study_first_submitted_qc>September 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2013</study_first_posted>
  <last_update_submitted>September 10, 2013</last_update_submitted>
  <last_update_submitted_qc>September 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kobe University</investigator_affiliation>
    <investigator_full_name>Hiromasa Otake</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Shear stress</keyword>
  <keyword>Optical coherence tomography</keyword>
  <keyword>Drug-eluting stents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

